ANNE-DREW BULLARD: Open Payments
NPI 1043077738 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,768 in 77 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,768
Food & beverage: $1,768
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $376 |
| Madrigal Pharmaceuticals | 10 | $352 |
| Aimmune Therapeutics, Inc. | 15 | $304 |
| EVOKE PHARMA, INC. | 10 | $239 |
| Janssen Biotech, Inc. | 6 | $214 |
| Ardelyx, Inc. | 3 | $62 |
| Celltrion USA Inc. | 2 | $47 |
| ORPHALAN INC | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| QOL Medical, LLC | 1 | $23 |
Products named: REZDIFFRA, ZENPEP, GIMOTI, TREMFYA, SKYRIZI, RINVOQ, IBSRELA, VEGZELMA.
Industry payments across TN — which companies pay providers there.
